vTv Therapeutics Inc.

NASDAQ:VTVT

Biotechnology

Healthcare
$16.36 +1.47%

+$0.50 today

Market cap
$64.69M
Beta
0.27
P/E (TTM)
128.7
EPS (TTM)
$0.27
52W Low $14.00High $44.00

Volume 0.02M

Average 0.05M

Balance Sheet

Inspect the capital base behind the business.

Assets

$89.90M

FY 2025 · Annual

+134.9% YoY

Liabilities

$25.46M

FY 2025 · Annual

+6.2% YoY

Equity

$64.44M

FY 2025 · Annual

+350.6% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents13.42M12.13M9.45M36.75M88.93M
Short-term Investments00000
Net Receivables57K12.42M102K62K0
Inventory100K0000
Other Current Assets35K15K65K113K218K
Total Current Assets15.62M27.09M10.66M38.11M89.89M
Property, Plant & Equipment (Net)680K556K361K153K0
Goodwill00000
Intangible Assets00000
Long-term Investments9.17M5.59M000
Tax Assets00000
Other Non-current Assets00006K
Total Non-current Assets9.85M6.14M361K153K6K
Total Assets25.47M33.24M11.02M38.27M89.9M
Account Payables1.88M2.46M4.08M939K1.13M
Short-term Debt256K224K191K00
Tax Payables00000
Deferred Revenue35K17K17K00
Other Current Liabilities3.2M788K4.7M1.51M2.17M
Total Current Liabilities8.5M7.71M10.62M5.2M6.64M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)018.67M18.67M18.67M18.67M
Other Non-current Liabilities1.26M684K110K100K152K
Total Non-current Liabilities1.75M19.69M18.95M18.77M18.82M
Total Liabilities10.25M27.4M29.57M23.97M25.46M
Common Stock901K27K27K32K39K
Retained Earnings(248.83M)(265.52M)(281.04M)(299.72M)(326.69M)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest24.96M16.58M6.13M2.1M0
Total Equity15.22M5.84M(18.55M)14.3M64.44M
Total Debt932K716K529K169K0
Net Debt(12.48M)(11.41M)(8.92M)(36.58M)(88.93M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$98.1M
Other Current$722.0K
Total Current Assets$98.8M
Other Non-current$5.0K
Total Non-current Assets$5.0K
Total Assets$98.8M

Analysis

Selected assets total $98.8M for Latest. The largest visible component is Cash & Equivalents at $98.1M, about 99.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
SC 13G/ASC 13G/A filingOct 8, 2026
8-KCurrent reportOct 6, 2026
10-QQuarterly reportAug 6, 2026

How much cash does VTVT have?

vTv Therapeutics Inc. (VTVT) reported $88.93M in cash and equivalents in fiscal 2025.

How much debt does VTVT carry?

vTv Therapeutics Inc. (VTVT) reported $0.00 of total debt, with net debt of -$88.93M.